Immunosuppressive regimens and long-term kidney transplant outcomes: A dual survival modeling framework
Kunle Apanisile, Meng-Hao Li, Hadi El-Amine, Naoru Koizumi · 2026
Read Immunosuppressive regimens and long-term kidney transplant outcomes: A dual survival modeling framework by Kunle Apanisile, Meng-Hao Li, Hadi El-Amine, Naoru Koizumi (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0339109.txt.
Description
Kunle Apanisile and three colleagues mine a huge transplant registry for the drug combinations that protect kidneys longest. Their 2026 study covers nearly two hundred twenty-nine thousand deceased-donor kidney recipients in the United States, transplanted between 2000 and 2024. Every recipient takes immune-suppressing drugs to stop rejection. Regimens vary, and their long-term trade-offs are contested. Classic survival models handled the clinical comparisons. Four machine learning survival models separately tested how well outcomes can be predicted.
One backbone combination stood out. Regimens built on calcineurin inhibitors plus mycophenolate carried lower hazards of graft failure. They also carried lower hazards of patient death. Adding steroids helped less than the simpler pairing. The scale of the data makes these differences hard to dismiss as noise. Transplant teams choosing maintenance therapy balance rejection against infection and cancer risk over decades. Registry evidence this large gives those lifelong choices a firmer empirical floor.
Catalog record
| CREATOR | Kunle Apanisile, Meng-Hao Li, Hadi El-Amine, Naoru Koizumi |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 52073 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |